$ADCT
ADC Therapeutics SA
XNYS•Health Care•Pharmaceutical Preparations
$1.58
▼-3.66%-$0.060Market closed
ADC Therapeutics SA
XNYS•Health Care•Pharmaceutical Preparations
Why is ADCT down today? It is at $1.58 (-3.66%), and our scanner flagged it 89 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ADCT spikes, and full due diligence on ADCT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ADCT 89 times in the last 30 days. Create a free account to track $ADCT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ADCT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ADCT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystADC Therapeutics Announces Abstracts at the 68thReported 88.7% ORR and 75.3% CR with ZYNLONTA plus glofitamab across the 97 efficacy-evaluable r/r DLBCL patientsReported robust and durable 93% ORR and 74.4% CRR with ZYNLONTA monotherapyReported 88.7%, and the complete response rate (CRR) was 75.3%., from the latest SEC filing. Read it →Across every filing on file, supply equal to at least 86.3% of the tradeable float is in play - 86.3% has already been sold.
Some filings did not state a size, so these are floors.
Recent share offering + active shelf on file — the company raised capital and can raise more
29,109,196 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Mallik Ameet Officer | Acquired (grant/award) | +675K 0.5% of company | added 47% | 2.12M | n/a | Jun 30, 26 |
Carmona Jose Officer | Acquired (grant/award) | +204K 0.2% of company | added 28% | 938K | n/a | Jun 30, 26 |
Graham Peter J Officer | Acquired (grant/award) | +221K 0.2% of company | added 36% | 842K | n/a | Jun 30, 26 |
Zaki Mohamed Officer | Acquired (grant/award) | +214K 0.2% of company | added 31% | 896K | n/a | Jun 30, 26 |
Coughlin Timothy Director | Sold (automatic/other) | -13K | sold 15% | 72K | $39K at $3.08 | Jun 3, 26 |
Bizzari Jean-Pierre Director | Sold (automatic/other) | -13K | sold 8.3% | 139K | $39K at $3.08 | Jun 3, 26 |
Hug Peter Director | Sold (automatic/other) | -2K | sold 0.8% | 263K | $7K at $3.08 | Jun 3, 26 |
Monges Viviane Director | Sold (automatic/other) | -3K | sold 1.4% | 186K | $8K at $3.08 | Jun 3, 26 |
Sandor Victor Director | Sold (automatic/other) | -13K | sold 8.2% | 141K | $39K at $3.08 | Jun 3, 26 |
Squarer Ron Director | Sold (automatic/other) | -15K 0.01% of company | sold 11% | 123K | $47K at $3.08 | Jun 3, 26 |
Azelby Robert Director | Sold (automatic/other) | -13K | sold 10% | 113K | $39K at $3.08 | Jun 3, 26 |
Coughlin Timothy Director | Acquired (grant/award) | +45K 0.04% of company | added 100% | 85K | n/a | Jun 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on ADCT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ADCT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
ADCT last traded at $1.58, down 3.66% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
ADC Therapeutics SA (ADCT) is next expected to report earnings on Monday, November 9, 2026 (before open), about 2 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ADCT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ADCT 89 times in the last 30 days.
ADCT (ADC Therapeutics SA) trades on XNYS, with a market cap of about $202M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ADCT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ADCT discussion
Sign in to ask a question or join the discussion.